The role of oestrogen receptor α in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2 (vol 17, pg 255, 2010)

被引：0
|
作者：
Kavanagh, Dara O. [1 ,2 ]
Mcilroy, Marie [1 ,2 ,3 ]
Myers, Eddie [1 ,2 ]
Bane, Fiona [3 ]
Crotty, Thomas B. [1 ,2 ]
Mcdermott, E. [1 ,2 ]
Hill, Arnold D. [1 ,2 ,3 ]
Young, Leonie S. [1 ,2 ,3 ]
机构：
[1] St Vincents Univ Hosp, UCD Conway Inst, Sch Med & Med Sci, Dublin, Ireland
[2] Univ Coll Dublin, Dublin, Ireland
[3] Royal Coll Surgeons Ireland, Endocrine Oncol Res Grp, Dept Surg, St Stephens Green, Dublin, Ireland
来源：
ENDOCRINE-RELATED CANCER | 2024年 / 31卷 / 12期
关键词：
D O I：
10.1530/ERC-09-0216e
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prognostic role of HER2 expression in patients with estrogen receptor positive/HER2-negative breast cancer. Results from a populationbased cancer registry study
    Tommasi, C.
    Coriano, M.
    Serra, O.
    Pellegrino, B.
    Zanoni, D.
    Faccini, F.
    Michiara, M.
    Sgargi, P.
    Giuliano, C.
    Ferretti, S.
    Grossi, V.
    Ravaioli, A.
    Zamagni, F.
    Falcini, F.
    Musolino, A.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 37 - 37
  • [32] A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections
    Hiroaki Nitta
    Brian D Kelly
    Mary Padilla
    Nikolaus Wick
    Patrick Brunhoeber
    Isaac Bai
    Shalini Singh
    Jim Ranger-Moore
    Chris Bieniarz
    Hitoshi Tsuda
    Thomas M Grogan
    Diagnostic Pathology, 7
  • [33] A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections
    Nitta, Hiroaki
    Kelly, Brian D.
    Padilla, Mary
    Wick, Nikolaus
    Brunhoeber, Patrick
    Bai, Isaac
    Singh, Shalini
    Ranger-Moore, Jim
    Bieniarz, Chris
    Tsuda, Hitoshi
    Grogan, Thomas M.
    DIAGNOSTIC PATHOLOGY, 2012, 7
  • [34] Towards the Goal of Personalized Medicine in Gastric Cancer - Time to Move Beyond HER2 Inhibition. Part I: Targeting Receptor Tyrosine Kinase Gene Amplification
    Lee, Jeeyun
    Ou, Sai-Hong Ignatius
    DISCOVERY MEDICINE, 2013, 15 (85) : 333 - 341
  • [35] A Molecular Modeling-Based Investigation Of The Intermolecular Interactions Between The Different Her2 Receptor Tyrosine Kinase Mutant Variants And Clinical Small Molecules In Lung Cancer
    Gow, C. -H.
    Liu, Y. -C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [36] Liver kinase B1 expression promotes phosphatase activity and abrogation of receptor tyrosine kinase phosphorylation in human cancer cells (vol 289, pg 1639, 2014)
    Okon, Imoh S.
    Coughlan, Kathleen A.
    Zou, Ming-Hui
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (33) : 12555 - 12555
  • [37] Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo
    Moulder, SL
    Yakes, FM
    Muthuswamy, SK
    Bianco, R
    Simpson, JF
    Arteaga, CL
    CANCER RESEARCH, 2001, 61 (24) : 8887 - 8895
  • [38] Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomized Trial of Paclitaxel With Lapatinib or Placebo As First-Line Treatment in HER2-Negative or Unknown Metastatic Breast Cancer
    Finn, Richard S.
    Press, Michael F.
    Dering, Judy
    Arbushites, Michael
    Koehler, Maria
    Oliva, Cristina
    Williams, Lisa S.
    Di Leo, Angelo
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (24) : 3908 - 3915
  • [39] Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment
    Akinnusi, Precious A.
    Olubode, Samuel O.
    Adebesin, Ayomide O.
    Nana, Toluwani A.
    Shodehinde, Sidiqat A.
    CANCER INFORMATICS, 2022, 21
  • [40] Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment
    Akinnusi, Precious A.
    Olubode, Samuel O.
    Adebesin, Ayomide O.
    Nana, Toluwani A.
    Shodehinde, Sidiqat A.
    CANCER INFORMATICS, 2022, 21
12345